We are live on ! Find out more
SMTI icon

Sanara MedTech

47 hedge funds and large institutions have $26.7M invested in Sanara MedTech in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

121% more capital inflows, than outflows

Capital inflows: $15.2M | Capital outflows: $6.86M

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

34% more funds holding

Funds holding: 35 → 47 (+12)

2.44% more ownership

Funds ownership: 5.52% → 7.96% (+2.4%)

Holders
47
Holders Change
+12
Holders Change %
+34.29%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
12
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SMTI Hedge Fund Activity: Q2 2023 in Review

47 of the 6,391 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2023, worth a combined $26.7M — up 40% from $19.1M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new SMTI positions and 7 closed out — a net gain of 12 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $6.7M. The largest seller was Millennium Management, exiting entirely with an estimated $1.58M sold.

  • 47 institutional investors held Sanara MedTech (SMTI) as of Q2 2023, up from 35 in Q1 2023.
  • Funds reported $26.7M of Sanara MedTech stock for Q2 2023, up 40% quarter-over-quarter.
  • 19 funds opened new Sanara MedTech positions in Q2 2023 and 7 closed out, a net change of +12 holders.
  • The largest Sanara MedTech buyer in Q2 2023 was BlackRock, an estimated $6.7M added.
  • The largest Sanara MedTech seller in Q2 2023 was Millennium Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q2 2023.